CVS Caremark Corporation (NYSE: CVS) announced today that it is changing its corporate name to CVS Health to reflect its broader health care commitment and its expertise in driving the innovations needed to shape the future of health.
As a further demonstration of its commitment to health, CVS Health also announced the end of tobacco sales at CVS/pharmacy as of September 3, nearly a month ahead of the previously targeted date of October 1. In February, the company announced that it would end the sale of cigarettes and tobacco products at its CVS/pharmacy stores, making CVS/pharmacy the first and only national pharmacy chain to take this step in support of the health and well-being of its patients and customers.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7308951-cvs-caremark-announces-corporate-name-change-to-cvs-health/
Technology leader Samsung Electronics Co. Ltd., together with global health service company Cigna, today announced a new version of the Coach by Cigna mobile application that features the psychology of lateral assessment to identify your personality type, understands your wants, needs and preferences, and provides the right programs to help with diet, exercise, sleep, stress and weight.
Coach by Cigna is available at no charge in the Google Play store for Samsung Galaxy S6, S6 Edge,
Galaxy S5, Galaxy Note 4 and Note Edge mobile devices.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7448831-coach-by-cigna-fitness-app/
Today, hotels.com® launched an exciting, “extreme” campaign centered on the company’s high-speed mobile booking application, which allows users to book rooms at its network of almost 140,000 worldwide hotels. To promote the idea that you can easily and quickly book a hotel room from almost anywhere, even at the very last minute, hotels.com has teamed up with extreme athlete and stuntman, JT Holmes, for a wild and exciting digital demonstration to prove just how easy it is to book a room while ‘on the fly’.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52014-hotels-com-launches-integrated-marketing-campaign-mobile-booking-app
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Altera Corporation (NASDAQ: ALTR) today announced it has achieved a significant milestone in transceiver technology by becoming the first company to successfully demonstrate 25-Gbps transceiver performance in programmable logic. Altera achieved this milestone in its 28-nm transceiver test chip, a prototyping platform that Altera is using to succeassfully deploy 28-Gbps transceivers on 28-nm FPGAs. Reaching the 25-Gbps milestone more than doubles the transceiver performance in currently available FPGA solutions, and rivals or exceeds the abilities of competitive ASSP offerings. A demonstration video of the 28-nm transceiver test chip is available for viewing on Altera's website.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/altera/43983/
